Dual-Acting Cholinesterase–Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo

A new and rapid colorimetric determination of acetylcholinesterase activity

Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90145-9 · Cited by 27,221 · see citing works

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404 · see citing works

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676 · see citing works

SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE

DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565 · see citing works

International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819 · see citing works

Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease

Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489 · see citing works

Identification and Functional Characterization of Brainstem Cannabinoid CB₂Receptors

Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470 · see citing works

Activation of microglial cells by β-amyloid protein and interferon-γ

Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314 · see citing works

Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.

(2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.03.49 · Cited by 1,288 · see citing works

Designed Multiple Ligands. An Emerging Drug Discovery Paradigm

Morphy, R., & Ranković, Z. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058225d · Cited by 1,237 · see citing works

Inflammation in Neurodegenerative Disease—A Double-Edged Sword

Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235 · see citing works

Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer Type

Summers, W. K., Majovski, L. V., Marsh, G. M., Tachiki, K. H., & Kling, A. S. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611133152001 · Cited by 1,161 · see citing works

The endocannabinoid system and the brain.

Mechoulam, R., & Parker, L. A. (2013) · Annual Review of Psychology · doi:10.1146/annurev-psych-113011-143739 · Cited by 1,090 · see citing works

An Update on Terminology and Reporting

Batts, K. P., & Ludwig, J. (1995) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199512000-00007 · Cited by 1,082 · see citing works

Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress

Murphy, T. H., Miyamoto, M., Sastre, A., Schnaar, R. L., & COYLE, J. T. (1989) · Neuron · doi:10.1016/0896-6273(89)90043-3 · Cited by 1,033 · see citing works

Apoptosis is induced by beta-amyloid in cultured central nervous system neurons.

Loo, D. T., Copani, A., Pike, C. J., Whittemore, E. R., Walencewicz, A. J., & Cotman, C. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7951 · Cited by 1,022 · see citing works

Calcium dyshomeostasis and intracellular signalling in alzheimer's disease

LaFerla, F. M. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn960 · Cited by 970 · see citing works

Neurobiology of butyrylcholinesterase

Darvesh, S., Hopkins, D. A., & Geula, C. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1035 · Cited by 896 · see citing works

Hepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease

Watkins, P. B. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510370044030 · Cited by 829 · see citing works

The effects of cannabinoids on the brain

Ameri, A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00087-2 · Cited by 805 · see citing works

Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent

Greig, N. H., Utsuki, T., Ingram, D. K., Wang, Y., Pepeu, G., Scali, C., Yu, Q.-S., Mamczarz, J., Holloway, H. W., Giordano, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508575102 · Cited by 745 · see citing works

Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine

Mesulam, M. M., Guillozet-Bongaarts, A. L., Shaw, P. L., Levey, A. I., Duysen, E. G., & Lockridge, O. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00613-3 · Cited by 654 · see citing works

Multiple Functions of Endocannabinoid Signaling in the Brain

Katona, I., & Freund, T. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150420 · Cited by 630 · see citing works

Cannabinoid CB2Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains

Benito, C., Núñez, E., Tolón, R. M., Carrier, E. J., Rábano, A., Hillard, C. J., & Romero, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11136.2003 · Cited by 624 · see citing works

Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E

Barger, S. W., & Harmon, A. D. (1997) · Nature · doi:10.1038/42257 · Cited by 622 · see citing works

Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches

Tsai, J., Grutzendler, J., Duff, K., & Gan, W.-B. (2004) · Nature Neuroscience · doi:10.1038/nn1335 · Cited by 561 · see citing works

Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction

Maurice, T., Lockhart, B. P., & Privat, A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01032-7 · Cited by 524 · see citing works

beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies.

Bartolini, M., Bertucci, C., Cavrini, V., & Andrisano, V. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01514-9 · Cited by 523 · see citing works

Oxytosis: a novel form of programmed cell death

Shirlee Tan, B. S. P., David Schubert, B. S. P., & Pamela Maher, B. S. P. (2001) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026013394741 · Cited by 522 · see citing works

The endocannabinoid system in guarding against fear, anxiety and stress

Lutz, B., Marsicano, G., Maldonado, R., & Hillard, C. J. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn4036 · Cited by 506 · see citing works

A New Therapeutic Target in Alzheimer's Disease Treatment: Attention to Butyrylcholinesterase

Greig, N. H., Utsuki, T., Yu, Q., Zhu, X., Holloway, H. W., Perry, T., Lee, B. H., Ingram, D. K., & Lahiri, D. K. (2001) · Current Medical Research and Opinion · doi:10.1185/03007990152673800 · Cited by 501 · see citing works

Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds

Proschak, E., Stark, H., & Merk, D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00760 · Cited by 498 · see citing works

Agonist‐inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630

Ross, R. A., Brockie, H. C., Stevenson, L., Murphy, V. L., Templeton, F., Makriyannis, A., & Pertwee, R. G. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702351 · Cited by 407 · see citing works

Oxidative stress signalling in Alzheimer's disease

Zhu, X., Raina, A. K., Lee, H., Casadesús, G., Smith, M. A., & Perry, G. L. (2004) · Brain Research · doi:10.1016/j.brainres.2004.01.012 · Cited by 390 · see citing works

Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease:

Grossberg, G. T. (2003) · Current Therapeutic Research · doi:10.1016/s0011-393x(03)00059-6 · Cited by 384 · see citing works

Organic Chemistry of Enzyme-Catalyzed Reactions

Silverman, R. B. (2002) · Elsevier eBooks · doi:10.1016/c2009-0-22837-6 · Cited by 380 · see citing works

Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation

Ehrhart, J. C., Obregon, D. F., Mori, T., Hou, H., Sun, N., Bai, Y., Klein, T., Fernandez, F., Tan, J., & Shytle, R. D. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-29 · Cited by 379 · see citing works

Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line

Davis, J. B., & Maher, P. A. (1994) · Brain Research · doi:10.1016/0006-8993(94)90334-4 · Cited by 358 · see citing works

A New Therapeutic Target in Alzheimer's Disease Treatment: Attention to Butyrylcholinesterase

Greig, N. H., Utsuki, T., Yu, Q.-S., et al. (2001) · Current Medical Research and Opinion · doi:10.1185/0300799039117057 · Cited by 352 · see citing works

Insight Into the Kinetic of Amyloid β (1–42) Peptide Self‐Aggregation: Elucidation of Inhibitors’ Mechanism of Action

Bartolini, M., Bertucci, C., Bolognesi, M. L., Cavalli, A., Melchiorre, C., & Andrisano, V. (2007) · ChemBioChem · doi:10.1002/cbic.200700427 · Cited by 348 · see citing works

Oxidative Stress Induces a Form of Programmed Cell Death with Characteristics of Both Apoptosis and Necrosis in Neuronal Cells

Tan, S., Wood, M. R., & Maher, P. A. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71010095.x · Cited by 337 · see citing works

Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study

Núñez, E., Benito, C., Pazos, M. R., Barbáchano, A., Fajardo, O., González, S. R., Tolón, R. M., & Romero, J. (2004) · Synapse · doi:10.1002/syn.20050 · Cited by 334 · see citing works

A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer’s disease

Nordberg, A., Ballard, C., Bullock, R., Darreh-Shori, T., & Somogyi, M. (2013) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.12r01412 · Cited by 323 · see citing works

Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer’s disease resemble embryonic development—A study of molecular forms

Arendt, T., Brückner, M. K., Lange, M., & Bigl, V. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90189-x · Cited by 314 · see citing works

Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine

Zemek, F., Drtinová, L., Nepovimová, E., Šepsová, V., Korábečný, J., Klimeš, J., & Kuča, K. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.914168 · Cited by 307 · see citing works

Sigma1 (σ1) receptor agonists and neurosteroids attenuate β25–35-amyloid peptide-induced amnesia in mice through a common mechanism

Maurice, T., Su, T., & Privat, A. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00405-3 · Cited by 291 · see citing works

The anti‐amnesic and neuroprotective effects of donepezil against amyloid β25‐35peptide‐induced toxicity in mice involve an interaction with theσ1receptor

Meunier, J., Ieni, J. R., & Maurice, T. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706927 · Cited by 289 · see citing works

Cholinergic function and Alzheimer's disease

Giacobini, E. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.935 · Cited by 284 · see citing works

Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice

Martín-Moreno, A. M., Brera, B., Spuch, C., Carro, E., García‐García, L., Delgado, M., Pozo, M. A., Innamorato, N. G., Cuadrado, A., & CEBALLOS, M. L. D. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-8 · Cited by 246 · see citing works

Synthetic cannabinoid WIN55,212‐2 inhibits generation of inflammatory mediators by IL‐1β‐stimulated human astrocytes

Sheng, W. S., Hu, S., Min, X. M., Cabral, G. A., Lokensgard, J. R., & Peterson, P. K. (2004) · Glia · doi:10.1002/glia.20108 · Cited by 246 · see citing works

Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.

Alas, S., & Bonavida, B. (2003) · PubMed · Cited by 240 · see citing works

Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors

Castro, A., & Martinez, A. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206778792985 · Cited by 207 · see citing works

Kinetic analysis of amyloid fibril polymerization in vitro.

Naiki, H., Higuchi, K., Nakakuki, K., & Takeda, T. (1991) · PubMed · Cited by 194 · see citing works

Bioisosteric Replacements of the Pyrazole Moiety of Rimonabant: Synthesis, Biological Properties, and Molecular Modeling Investigations of Thiazoles, Triazoles, and Imidazoles as Potent and Selective CB1Cannabinoid Receptor Antagonists

Lange, J. H. M., van Stuivenberg, H. H., Coolen, H. K. A. C., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040843r · Cited by 181 · see citing works

Activation of the CB2 receptor system reverses amyloid-induced memory deficiency

Wu, J., Bie, B., Yang, H., Xu, J. J., Brown, D. L., & Naguib, M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.011 · Cited by 174 · see citing works

Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia

Ferrer, I. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.03.005 · Cited by 174 · see citing works

cAMP detection methods in HTS: selecting the best from the rest

Williams, C. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1306 · Cited by 170 · see citing works

Tacrine: A pharmacological review

Freeman, S. E., & Dawson, R. M. (1991) · Progress in Neurobiology · doi:10.1016/0301-0082(91)90002-i · Cited by 168 · see citing works

Blockade of Tau Hyperphosphorylation and Aβ1–42 Generation by the Aminotetrahydrofuran Derivative ANAVEX2-73, a Mixed Muscarinic and σ1 Receptor Agonist, in a Nontransgenic Mouse Model of Alzheimer’s Disease

Lahmy, V., Meunier, J., Malmström, S., Naert, G., Givalois, L., Kim, S. H., Villard, V., Vamvakides, A., & Maurice, T. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.70 · Cited by 163 · see citing works

Excessive hippocampal acetylcholine levels in acetylcholinesterase‐deficient mice are moderated by butyrylcholinesterase activity

Hartmann, J., Kiewert, C., Duysen, E. G., Lockridge, O., Greig, N. H., & Klein, J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04347.x · Cited by 158 · see citing works

Time-Course and Regional Analyses of the Physiopathological Changes Induced after Cerebral Injection of an Amyloid β Fragment in Rats

Zussy, C., Brureau, A., Delair, B., Marchal, S., Keller, E., IXART, G., Naert, G., Meunier, J., Chevallier, N., Maurice, T., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.021 · Cited by 151 · see citing works

Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in mice

Furukawa‐Hibi, Y., Alkam, T., Nitta, A., Matsuyama, A., Mizoguchi, H., Suzuki, K., Moussaoui, S. M., Yu, Q.-S., Greig, N. H., Nagai, T., et al. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.07.035 · Cited by 150 · see citing works

Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide‐induced nitric oxide release in astrocyte cultures

Molina‐Holgado, F., Molina‐Holgado, E., Guaza, C., & Rothwell, N. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10165 · Cited by 148 · see citing works

<i>In vitro</i>and<i>in vivo</i>characterization of A‐796260: a selective cannabinoid CB₂receptor agonist exhibiting analgesic activity in rodent pain models

Yao, B. B., Hsieh, G. C., Frost, J. M., Fan, Y., Garrison, T. R., Daza, A. V., Grayson, G. K., Zhu, C. Z., Pai, M., Chandran, P., et al. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707568 · Cited by 140 · see citing works

Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma ₁ (σ ₁ ) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative

Villard, V., Espallergues, J., Keller, E., Vamvakides, A., & Maurice, T. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110379286 · Cited by 139 · see citing works

Novel Tacrine–Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography

Zha, X., Lamba, D., Zhang, L., Lou, Y., Xu, C., Kang, D., Chen, L., Xu, Y., Zhang, L., Simone, A. D., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01119 · Cited by 133 · see citing works

Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer’s disease (1998–2018)

Mishra, P., Kumar, A., & Panda, G. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.01.025 · Cited by 128 · see citing works

Mechanism mediating oligomeric Aβ clearance by naïve primary microglia

Yang, C.-N., Shiao, Y.-J., Shie, F., Guo, B.-S., Chen, P.-H., Cho, C.-Y., Chen, Y., Huang, F.-L., & Tsay, H.-J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.005 · Cited by 125 · see citing works

Antiamnesic and Neuroprotective Effects of the Aminotetrahydrofuran Derivative ANAVEX1-41 Against Amyloid β25–35-Induced Toxicity in Mice

Villard, V., Espallergues, J., Keller, E., Alkam, T., Nitta, A., Yamada, K., Nabeshima, T., Vamvakides, A., & Maurice, T. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.212 · Cited by 105 · see citing works

Homodimeric Tacrine Congeners as Acetylcholinesterase Inhibitors

Hu, M., Wu, L.-J., Hsiao, G., & Yen, M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010308g · Cited by 104 · see citing works

Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors

Mukherjee, S., Adams, M., Whiteaker, K. L., Daza, A. V., Kage, K., Cassar, S. C., Meyer, M., & Yao, B. B. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.09.058 · Cited by 99 · see citing works

Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer’s disease treatment

Minarini, A., Milelli, A., Tumiatti, V., Rosini, M., Simoni, E., Bolognesi, M. L., Andrisano, V., Bartolini, M., Motori, E., Angeloni, C., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.10.007 · Cited by 85 · see citing works

Tacrine-Silibinin Codrug Shows Neuro- and Hepatoprotective Effects in Vitro and Pro-Cognitive and Hepatoprotective Effects in Vivo

Chen, X., Zenger, K., Lupp, A., Kling, B., Heilmann, J., Fleck, C., Kraus, B., & Decker, M. W. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300246n · Cited by 76 · see citing works

Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain

Seltzman, H. H., Shiner, C., Hirt, E. E., Gilliam, A. F., Thomas, B. F., Maitra, R., Snyder, R. W., Black, S. R., Patel, P. R., Mulpuri, Y., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00516 · Cited by 75 · see citing works

CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease

Koppel, J. L., Vingtdeux, V., Marambaud, P., d’Abramo, C., Jimenez, H. T., Stauber, M., Friedman, R., & Davies, P. (2013) · Molecular Medicine · doi:10.2119/molmed.2013.00140.revised · Cited by 74 · see citing works

Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse

Maurice, T., Strehaïano, M., Siméon, N., Bertrand‐Gaday, C., & Chatonnet, A. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.08.026 · Cited by 73 · see citing works

Type-2 cannabinoid receptors in neurodegeneration

Bisogno, T., Oddi, S., Piccoli, A., Fazio, D., & Maccarrone, M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.07.021 · Cited by 71 · see citing works

Structure–Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles

Dolles, D., Hoffmann, M., Gunesch, S., Marinelli, O., Möller, J., Santoni, G., Chatonnet, A., Lohse, M. J., Wittmann, H.-J., Strasser, A., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01760 · Cited by 67 · see citing works

Novel benzimidazole derivatives as selective CB2 agonists

Pagé, D., Balaux, É., Boisvert, L., Liu, Z., Milburn, C., Tremblay, M., Wei, Z., Woo, S., Luo, X., Cheng, Y., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.05.073 · Cited by 66 · see citing works

Comparison Analysis of Gene Expression Patterns between Sporadic Alzheimer's and Parkinson's Disease

Grünblatt, E., Zander, N., Bartl, J., Li, J., Monoranu, C., Arzberger, T., Ravid, R., Roggendorf, W., Gerlach, M., & Riederer, P. F. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12402 · Cited by 59 · see citing works

Transcriptional Activation of the Macrophage Migration-Inhibitory Factor Gene by the Corticotropin-Releasing Factor is Mediated by the Cyclic Adenosine 3',5'-Monophosphate Responsive Element-Binding Protein CREB in Pituitary Cells

Waeber, G., Thompson, N. A., Chautard, T., Steinmann, M., NICOD, P. H., Pralong, F. P., Calandra, T., & Gaillard, R. C. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.5.0109 · Cited by 58 · see citing works

Mu-opioid Receptors Facilitate the Propagation of Excitatory Activity in Rat Hippocampal Area CA1 by Disinhibition of all Anatomical Layers

McQuiston, A. R., & Saggau, P. (2003) · Journal of Neurophysiology · doi:10.1152/jn.01150.2002 · Cited by 58 · see citing works

Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response

Zheng, Y., Wang, Q., Li, T., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw131 · Cited by 56 · see citing works

Tacrine-based Multifunctional Agents in Alzheimer's Disease: An Old Story in Continuous Development§

Milelli, A., Simone, A. D., Ticchi, N., et al. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170309123920 · Cited by 52 · see citing works

The γ-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Aβ1–42 seeding and short-term memory deficits in the Aβ25–35 mouse model of Alzheimer's disease

Meunier, J., Villard, V., Givalois, L., & Maurice, T. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.10.033 · Cited by 41 · see citing works

Structure and functional analysis of the human STAT3 gene promoter: alteration of chromatin structure as a possible mechanism for the upregulation in cisplatin-resistant cells

Kato, K., Nomoto, M., Izumi, H., Ise, T., Nakano, S., Niho, Y., & Kohno, K. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00168-8 · Cited by 40 · see citing works

Aminobenzimidazoles and Structural Isomers as Templates for Dual‐Acting Butyrylcholinesterase Inhibitors and hCB2R Ligands To Combat Neurodegenerative Disorders

Dolles, D., Nimczick, M., Scheiner, M., Ramler, J., Stadtmüller, P., Sawatzky, E., Drakopoulos, A., Sotriffer, C., Wittmann, H., Straßer, A., et al. (2015) · ChemMedChem · doi:10.1002/cmdc.201500418 · Cited by 39 · see citing works

Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core

Lin, H., Li, Q., Gu, K. X., Zhu, J., Jiang, X., Chen, Y., & Sun, H. (2017) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026617666170717114944 · Cited by 38 · see citing works

Hepatotoxicity of dimethylformamide and dimethylsulfoxide at and above the levels used in some aflatoxin studies.

Mathew, T., Karunanithy, R., Yee, M. H., et al. (1980) · PubMed · Cited by 35 · see citing works

Cytochrome P450 binding studies of novel tacrine derivatives: Predicting the risk of hepatotoxicity

McEneny‐King, A., Osman, W., Edginton, A. N., & Rao, P. P. N. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.04.006 · Cited by 34 · see citing works

Regioselective synthesis of 7-O-esters of the flavonolignan silibinin and SARs lead to compounds with overadditive neuroprotective effects

Schramm, S., Huang, G., Gunesch, S., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.01.036 · Cited by 30 · see citing works

New Approaches in the Design and Development of Cannabinoid Receptor Ligands: Multifunctional and Bivalent Compounds

Nimczick, M., & Decker, M. W. (2015) · ChemMedChem · doi:10.1002/cmdc.201500041 · Cited by 28 · see citing works

CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease

Koppel, J. L., Vingtdeux, V., Marambaud, P., d’Abramo, C., Jimenez, H. T., Stauber, M., Friedman, R., & Davies, P. (2013) · Molecular Medicine · doi:10.2119/molmed.2013.00140 · Cited by 27 · see citing works

The First Photochromic Affinity Switch for the Human Cannabinoid Receptor 2

Dolles, D., Straßer, A., Wittmann, H., et al. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201700032 · Cited by 25 · see citing works

Synthesis and biological evaluation of bivalent cannabinoid receptor ligands based on hCB2R selective benzimidazoles reveal unexpected intrinsic properties

Nimczick, M., Pemp, D., Darras, F. H., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.06.008 · Cited by 22 · see citing works

Pyrazole antagonists of the CB1 receptor with reduced brain penetration

Fulp, A. B., Zhang, Y., Bortoff, K. D., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.01.033 · Cited by 22 · see citing works

In-vitro stability and metabolism of a tacrine–silibinin codrug

Zenger, K., Chen, X., Decker, M., & Kraus, B. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12070 · Cited by 13 · see citing works

Investigations into neuroprotectivity, stability, and water solubility of 7‐O‐cinnamoylsilibinin, its hemisuccinate and dehydro derivatives

Schramm, S., Gunesch, S., Lang, F. J. W., et al. (2018) · Archiv der Pharmazie · doi:10.1002/ardp.201800206 · Cited by 9 · see citing works

Dual-Acting Compounds Acting as Receptor Ligands and Enzyme Inhibitors

Dolles, D., & Decker, M. W. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-101011-2.00005-2 · Cited by 7 · see citing works

From combinations to multitarget-directed ligands: A continuum in Alzheimer’s disease polypharmacology

Albertini, C., Salerno, A., de Sena Murteira Pinheiro, P., & Bolognesi, M. L. (2021) · Medicinal Research Reviews · doi:10.1002/med.21699 · Cited by 179 · see citing works

Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice

Viayna, E., Coquelle, N., Cieslikiewicz-Bouet, M., Cisternas, P., Oliva, C. A., Sánchez-López, E., Ettcheto, M., Bartolini, M., De Simone, A., Ricchini, M., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01775 · Cited by 106 · see citing works

Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects <i>In Vitro</i> and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model

He, F., Chou, C. J., Scheiner, M., Poeta, E., Yuan Chen, N., Gunesch, S., Hoffmann, M., Sotriffer, C., Monti, B., Maurice, T., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01940 · Cited by 66 · see citing works

Cannabinoid Ligand-Receptor Signaling During Early Pregnancy in the Mouse

Paria, B. C., Das, S., & Dey, S. K. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_40 · Cited by 3 · see citing works

[Contribution on cholinesterase in vivo. I. Determination of cholinesterase activity in vivo].

FEHER, O., & Bokri, E. (1960) · PubMed · Cited by 1 · see citing works

Cannabinoid–improgan cross-tolerance: Improgan is a cannabinomimetic analgesic lacking affinity at the cannabinoid CB1 receptor

Nalwalk, J. W., Svokos, K. A., & Hough, L. B. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.035 · Cited by 9 · see citing works

Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes

Wiley, J. L., & Martin, B. R. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00146-9 · Cited by 100 · see citing works

Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles

Jansen, E. M., Haycock, D. A., Ward, S. J., & Seybold, V. S. (1992) · Brain Research · doi:10.1016/0006-8993(92)90428-c · Cited by 140 · see citing works